Authors:
Haraguchi, M
Border, WA
Huang, YF
Noble, NA
Citation: M. Haraguchi et al., t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis, KIDNEY INT, 59(6), 2001, pp. 2146-2155
Citation: Wa. Border et Na. Noble, Effect of maximal reduction of angiotensin in renal fibrosis: Bad news-good news from a pediatric mouse - Discussion, AM J KIDNEY, 35(4), 2000, pp. 773-775
Citation: H. Peters et al., Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis, KIDNEY INT, 57(4), 2000, pp. 1493-1501
Citation: H. Peters et al., Tandem antifibrotic actions of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis, KIDNEY INT, 57(3), 2000, pp. 992-1001
Citation: H. Peters et al., From rats to man: a perspective on dietary L-arginine supplementation in human renal disease, NEPH DIAL T, 14(7), 1999, pp. 1640-1650
Citation: H. Peters et al., L-Arginine supplementation increases mesangial cell injury and subsequent tissue fibrosis in experimental glomerulonephritis, KIDNEY INT, 55(6), 1999, pp. 2264-2273
Authors:
Isaka, Y
Akagi, Y
Ando, Y
Tsujie, M
Sudo, T
Ohno, N
Border, WA
Noble, NA
Kaneda, Y
Hori, M
Imai, E
Citation: Y. Isaka et al., Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis, KIDNEY INT, 55(2), 1999, pp. 465-475